BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 36790767)

  • 21. Management of HCC.
    de Lope CR; Tremosini S; Forner A; Reig M; Bruix J
    J Hepatol; 2012; 56 Suppl 1():S75-87. PubMed ID: 22300468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indian Council of Medical Research consensus document on hepatocellular carcinoma.
    Sirohi B; Shrikhande SV; Gaikwad V; Patel A; Patkar S; Goel M; Bal M; Sharma A; Shrimali RK; Bhatia V; Kulkarni S; Srivastava DN; Kaur T; Dhaliwal RS; Rath GK;
    Indian J Med Res; 2020 Nov; 152(5):468-474. PubMed ID: 33707388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
    Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
    J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular Carcinoma: Review of Epidemiology, Screening, Imaging Diagnosis, Response Assessment, and Treatment.
    Clark T; Maximin S; Meier J; Pokharel S; Bhargava P
    Curr Probl Diagn Radiol; 2015; 44(6):479-86. PubMed ID: 25979220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of Hepatocellular Carcinoma: Current Status and Future Directions.
    Au JS; Frenette CT
    Gut Liver; 2015 Jul; 9(4):437-48. PubMed ID: 26087860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical heterogeneity in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma.
    Anastasopoulos NT; Lianos GD; Tatsi V; Karampa A; Goussia A; Glantzounis GK
    Expert Rev Gastroenterol Hepatol; 2020 Nov; 14(11):1025-1033. PubMed ID: 32746645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Updated treatment approach to hepatocellular carcinoma.
    Llovet JM
    J Gastroenterol; 2005 Mar; 40(3):225-35. PubMed ID: 15830281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016.
    Yu SJ
    Clin Mol Hepatol; 2016 Mar; 22(1):7-17. PubMed ID: 27044761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatocellular carcinoma].
    Semela D; Heim M
    Ther Umsch; 2011 Apr; 68(4):213-7. PubMed ID: 21452143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interventional oncology for hepatocellular carcinoma.
    Delicque J; Boulin M; Guiu B; Pelage JP; Escal L; Schembri V; Assenat E; Fohlen A
    Clin Res Hepatol Gastroenterol; 2016 Nov; 40(5):530-537. PubMed ID: 27055387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular Carcinoma.
    Gilles H; Garbutt T; Landrum J
    Crit Care Nurs Clin North Am; 2022 Sep; 34(3):289-301. PubMed ID: 36049848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular carcinoma: systemic therapies and future perspectives.
    Mikhail S; Cosgrove D; Zeidan A
    Expert Rev Anticancer Ther; 2014 Oct; 14(10):1205-18. PubMed ID: 25199765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interventional treatment for unresectable hepatocellular carcinoma.
    Murata S; Mine T; Sugihara F; Yasui D; Yamaguchi H; Ueda T; Onozawa S; Kumita S
    World J Gastroenterol; 2014 Oct; 20(37):13453-65. PubMed ID: 25309076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008.
    Verslype C; Van Cutsem E; Dicato M; Arber N; Berlin JD; Cunningham D; De Gramont A; Diaz-Rubio E; Ducreux M; Gruenberger T; Haller D; Haustermans K; Hoff P; Kerr D; Labianca R; Moore M; Nordlinger B; Ohtsu A; Rougier P; Scheithauer W; Schmoll HJ; Sobrero A; Tabernero J; van de Velde C
    Ann Oncol; 2009 Jun; 20 Suppl 7():vii1-vii6. PubMed ID: 19497945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology and Management of Hepatocellular Carcinoma.
    Kulik L; El-Serag HB
    Gastroenterology; 2019 Jan; 156(2):477-491.e1. PubMed ID: 30367835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment options for hepatocellular carcinoma.
    Sandhu DS; Tharayil VS; Lai JP; Roberts LR
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):81-92. PubMed ID: 19072372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current treatment for hepatocellular carcinoma.
    Cahill BA; Braccia D
    Clin J Oncol Nurs; 2004 Aug; 8(4):393-9. PubMed ID: 15354926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The treatment of hepatocellular carcinoma: an update].
    Vero V; Racco S; Biolato M; Pompili M; Gasbarrini G; Miele L; Grieco A
    Minerva Med; 2009 Jun; 100(3):173-93. PubMed ID: 19571783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Embolotherapy of unresectable hepatocellular carcinoma: Eastern perspective.
    Lu J; Zhong BY; Zhu HD; Guo JH; Teng GJ
    Chin Clin Oncol; 2019 Dec; 8(6):60. PubMed ID: 31865712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular carcinoma: diagnosis, management, and prognosis.
    Page AJ; Cosgrove DC; Philosophe B; Pawlik TM
    Surg Oncol Clin N Am; 2014 Apr; 23(2):289-311. PubMed ID: 24560111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.